Examining Perceptions of the 24-Hr Movement Guidelines

September 28, 2021 updated by: Dr. Amy Latimer-Cheung, PhD

Examining Perceptions and Brand Approaches for the Canadian 24-Hour Movement Guidelines for Adults

The main objective of the proposed research is to experimentally test and inform the most effective brand attributes that is to be featured in the forthcoming Canadian 24-Hour Movement Guidelines for Adults. Specifically, there are two main objectives. The first objective is to determine the most preferred tagline associated with the new Guidelines among a sample of Canadian adults. The second objective is to experimentally test if this new attribute fosters stronger perceptions of self-efficacy among an adult sample, when compared to previous threshold-based approaches.

Study Overview

Status

Completed

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

247

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Ontario
      • Kingston, Ontario, Canada, K7L3N6
        • School of Kinesiology and Health Studies

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 64 years (Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • between 18-64 years
  • Canadian

Exclusion Criteria:

  • cannot read/write in English
  • already self-reported meeting Guideline recommendations for all three behaviours (physical activity, sedentary behaviour, and sleep)
  • self-reported medical condition and/or sleep condition that would prevent individual from meeting the Guideline recommendations

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Intervention (Generic Message)
Receives promotional materials that feature a generic messaging approach.
Exposed to four sets of promotional materials hypothesized to increase perceptions of self-efficacy to meet Guidelines.
No Intervention: Control (Threshold Message)
Receives promotional materials that use traditional, threshold messages.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Change in participants self-efficacy to meet Guidelines measured using the Multi-Dimensional Self-efficacy for Exercise Scale (adapted, scale 0-10; 0=not at all confident, 10=extremely confident) following pre and post exposure to promotional materials.
Time Frame: 3 time points: measuring change from baseline, immediately after viewing message, 2-week follow up
3 time points: measuring change from baseline, immediately after viewing message, 2-week follow up

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Amy E Latimer-Cheung, PhD, Queen's University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 20, 2020

Primary Completion (Actual)

February 24, 2020

Study Completion (Actual)

February 24, 2020

Study Registration Dates

First Submitted

February 18, 2020

First Submitted That Met QC Criteria

February 20, 2020

First Posted (Actual)

February 24, 2020

Study Record Updates

Last Update Posted (Actual)

September 30, 2021

Last Update Submitted That Met QC Criteria

September 28, 2021

Last Verified

September 1, 2021

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Health Behavior

Clinical Trials on Generic Message

Subscribe